Biotech Values

[jbog]

10nisman,

It was you who wrote to ThomasS this summation when the stock was at $22.


MNTA currently is one of the best risk-return investments in the entire market (I cannot think of a better one as I type). Upside potential is huge (200%+) and downside is maybe 15-20%. Insider tax selling is complete, MNTA will get favorable news August 17th, potential positive Copaxone news could take place anyday and in the mean-time Sandoz is seeing very good uptake in selling Lovenox.

The stock has traded down as much as 47% since that time, but for some reason You seem to think other people's statements aren't reasonable.